TuesdayJun 03, 2025 11:15 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Develop 6.9 MW Community Solar Project in Nova Scotia

SolarBank has announced it will develop a 6.9 MW Brooklyn solar project, located in Nova Scotia and expected to power approximately 900 homes, under Canada’s first Community Solar Program. The initiative supports Nova Scotia’s target of 80% renewable energy by 2030 and net-zero emissions by 2035. AI Renewable Fund owns the project; SolarBank serves as developer and builder. Construction is scheduled to begin in Spring 2026 and complete by Summer 2026, with total development cost estimated at $13.9 million. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable…

Continue Reading

MondayJun 02, 2025 11:10 am

D-Wave Quantum Inc. (NYSE: QBTS) Launches Commercial Availability of Advantage2(TM) Quantum System

Advantage2 offers a 4,400+ qubit processor with improved coherence and connectivity The system targets real-world applications in optimization, materials simulation, and AI, and features a 75% reduction in noise and a 40% energy scale increase over the predecessor Advantage(TM) quantum system Customers can access the Advantage2 system via D-Wave’s Leap(TM) cloud service or deploy it on-premises The Advantage2 system represents a remarkable achievement in helping customers realize value from quantum computing right now, said CEO Dr. Alan Baratz D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has officially announced the general availability of…

Continue Reading

MondayJun 02, 2025 10:00 am

Korean Researchers Develop AI to Predict Cancer Patients’ Response to Immunotherapy

A research team whose leadership is based in South Korea has developed an AI model for predicting how cancer patients will respond to immunotherapy. Designed to improve the precision of treatment in colorectal and gastric cancer, the AI model could provide physicians with a significantly more accurate tool for customizing therapies. Immunotherapy is a relatively new approach to cancer treatment that involves “training” the immune system to recognize and destroy malignant cells. In contrast to chemotherapy and radiation which can damage surrounding healthy tissue, immunotherapy allows physicians to more precisely target tumor cells. As a result, many patients undergoing immunotherapy…

Continue Reading

Contact us: (512) 354-7000